Keya Medical

06/20/2025

Thanks to Calantic™ Digital Solutions, we can share the first Bayer AI Imaging TechTalk between Mary-Pierre Waiss (Keya Medical) and Michael Claytor (Bayer) about DeepVessel FFR, a noninvasive, AI-powered CT analysis tool for coronary artery disease.

DeepVessel FFR — a deep learning-driven CT analysis — brings catheter‑lab precision to the CT suite, enabling non-invasive fractional flow reserve (FFR) assessment right from CCTA.

✅ Interactive 3D heart model and PDF report

✅ Instant physiological insights

✅ Fully reimbursed (CPT 75580)

✅ Integrated into Bayer’s Calantic platform

Watch "Bringing Cath-Lab Precision to the CT Suite: A Conversation on DeepVessel FFR". Bayer AI Imaging TechTalk: Speaking with Keya Medical.

03/18/2025

Join us this Thursday, March 20 | 12 PM – 1 PM EST for a FREE sponsored webinar on AI-Derived Decision-Making and Assessment in Coronary Artery Disease (CAD).

**AI-derived decision-making and assessment in CAD** Join us for a FREE online webinar featuring Armin Zadeh, MD, MSCCT; Michael Blaha, MD, MPH; Dinesh Kalra, MD, FSCCT and Irfan Shafique, MD discussing DeepVessel FFRCT, AI plaque analysis, and biomarkers in risk stratification, diagnosis, predictin...

03/12/2025

FREE SCCT Webinar sponsored by Keya Medical – AI in CAD Assessment & Decision-Making

Join us for an insightful SCCT webinar exploring the role of AI-derived decision-making and assessment in CAD, featuring expert discussions on DeepVessel FFRCT, AI plaque analysis, and biomarkers for risk stratification, diagnosis, and predicting acute coronary syndrome.

🗓 Thursday, March 20
⏰ 12:00 PM – 1:00 PM EST
💻 Virtual | FREE to attend
Register now: https://scct.org/events/EventDetails.aspx?id=1941719&group=&_zs=3CKFd&_zl=HaSQ4

Speakers & Panelists:
Irfan Shafique, MD (Moderator)
Armin Zadeh, MD, MSCCT
Michael Blaha, MD, MPH
Dinesh Kalra, MD, FSCCT

03/06/2025

AI in Cardiac Diagnostics: Moving Beyond Standard Coronary Anatomical Assessment

At in Amsterdam, Dr. Irfan Shafique introduced DEEPVESSEL FFR, Keya Medical's AI-driven CT-FFR solution designed to enhance non-invasive cardiac diagnostics.

In his presentation, "AI in CTFFR Analysis," Dr. Shafique showcased study cases demonstrating how DeepVessel FFR leverages deep learning to go beyond standard coronary anatomical assessment—delivering advanced physiological insights that support more precise, efficient, and patient-centered cardiovascular care.

At SCCT Global 2025, Dr. Shafique introduced DEEPVESSEL FFR, Keya Medical's AI-CT FFR designed to enhance non-invasive cardiac diagnostics.

08/19/2024

Advances in heart imaging and cardiovascular care. Learn how AI, including Keya Medical's CT FFR analysis DeepVessel FFR, makes diagnosis and treatment more precise. Check out the latest article in Radiology Today Magazine for more details.

Radiology Today newsmagazine reaches 40,000 radiology professionals nationwide on a monthly basis, covering areas such as Radiology Management, Bone Densitometry, Mammography, MRI, PACS, CT, Sonography, Nuclear Medicine, Radiation Oncology, Radiation Therapy, contrast agents, and more!

07/11/2024

Learn about the latest in Keya Medical’s FFR CT analysis in our new blog, “DEEPVESSEL FFR CT-Recent Peer-Reviewed Publications.” Discover how the deep learning-based DEEPVESSEL FFR is used in recent studies and how you can implement this accurate and economical solution into your workflow. Read more at https://www.keyamedical.com/deepvessel-ffr-ct-publications.

Following is a sampling of recent peer-reviewed publications and more studies with DEEPVESSEL FFR CT are in progress.

07/20/2023

Discover the insights from Dr. Rumberger's physician perspective and study case from Corazon Imaging using Keya Medical AI CT-FFR analysis DEEPVESSEL FFR.
https://www.keyamedical.com/corazon-keya-medical-case-study

02/01/2023

Sharing the announcement on AuntMinnie about Keya Medical's FFR CT solution. Contact us for a demo and free trial!

Keya Medical said that its DeepVessel artificial intelligence (AI)-based software for fractional flow reserve (FFR)-CT analysis is now available for clinical use in the U.S.

02/01/2023

Keya Medical is excited to announce that DEEPVESSEL FFR, a deep-learning-based FFR CT analysis, is now available in the USA.

Deep-learning based, non-invasive, accurate, and accessible CT-FFR test helps physicians diagnose and treat heart decease.

12/01/2021

A study conducted by researchers from Nanjing University, Keya Medical, and the Medical University of South Carolina, has demonstrated the accuracy of a deep-learning method to quantify CAC scores from a single CTA scan, with 93% of scans categorized correctly.

Calcium Scoring from Coronary CT Angiography Using Deep Learning - New study by Keya Medical and the Medical University of South Carolina.

11/23/2021

What is new in the 2021 AHA/ACC Guidelines for the Evaluation and Diagnosis of Chest Pain? Learn more about shared decision-making, structured assessment, and the increased interest in Coronary CTA as a first-line test and CT-FFR as an add-on test.

CCTA as a First Line Test and FFR-CT as an Add-on Test, SCCT Webcasts, Structured Assessment, CCTA and FFR-CT Utilization Growth Seen

09/22/2021

Health data interoperability standards such as FHIR are gathering momentum within the developer community. Micky Tripathi heads the HHS Office of the National Coordinator (ONC), the principal federal agency responsible for coordinating US efforts to implement standards-based health data exchange, and shared his perspectives at a community forum earlier this month. Ed Butler summarizes the discussion between Dr. Tripathi and Cambia Grove’s 2021 Innovation Fellows in this post: https://www.cambiagrove.com/blog/ready-aim-fhir-future-interoperability